完整心脏阻塞诊断后的氧化和与患者结果的关系:描述性队列研究
Elizabeth L Carter1, Juliana Gebb2, Christopher Janson1
1Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Prenatal diagnosis
|December 11, 2025
概括
氧化可能会改善被诊断为先天性完全心脏阻塞 (CHB) 的胎儿的结果,即使在诊断后开始使用. 这表明氧化可能是CHB的有益治疗方法.
科学领域:
- 孕产妇和胎儿的医学
- 儿科心脏病学 儿科心脏病学
- 免疫学 免疫学 免疫学
背景情况:
- 先天性完全心脏阻塞 (CHB) 是一种严重的疾病,死亡率高.
- 众所周知,母亲使用氧化可预防后期怀孕中的CHB.
- 在CHB诊断后开始的氧化的疗效尚未得到充分研究.
研究的目的:
- 调查氧化对CHB病例中胎儿结果的影响.
- 要确定氧化,即使在CHB诊断后开始使用,是否会改善结果.
- 将时间到心脏起器安置作为主要结果指标.
主要方法:
- 一个回顾性单一中心研究,涉及42名由于母体抗SSA抗体导致的CHB患者 (2005-2024年).
- 所有患者都接受了德克萨米他;24人接受了德克萨米他+氧化.
- 分析了氧化启动时间 (在CHB诊断之前或之后).
主要成果:
- 只有使用德克萨米他时,胎儿水更常见 (p=0.004).
- 甲甲 + 氧化 (p=0.003) 治疗时,氧化的发生频率更高.
- 虽然在仅服用德克萨米他的组中,出生时的节奏更高 (p=0.045),但到心脏起器安置的时间和长期存活率没有显著差异.
结论:
- 仅用德克萨米他组的更高的胎儿水率和需要节奏建议氧化可能有好处,即使在CHB诊断后开始使用.
- 样本的小规模限制了最终的结论;进一步的多中心研究是有必要的.
- 辅助氧化治疗可以改善CHB的结果,无论启动时间如何.
更多相关视频
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
4.1K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.9K
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
443
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
443
01:30Acute Coronary Syndrome III: Diagnostic Studies
197
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
197
01:22Heart Failure Drugs: β-Blockers
729
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
729
01:21Rheumatic Heart Disease III: Medical Management
264
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
01:20Rheumatic Heart Disease IV: Nursing Management
247
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
247
01:30Heart Failure IV: Classification and Diagnostic Evaluation
293
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
293